{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:49:08Z","timestamp":1790718548365,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-11-IDEX-0001-02"],"award-info":[{"award-number":["ANR-11-IDEX-0001-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.yebeh.2017.07.016","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T02:18:58Z","timestamp":1502763538000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Evaluating quality of life in epilepsy: The role of screening for adverse drug effects, depression, and anxiety"],"prefix":"10.1016","volume":"75","author":[{"given":"Jean-Arthur","family":"Micoulaud-Franchi`","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"McGonigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2017.07.016_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.12603","article-title":"More than seizures: improving the lives of people with refractory epilepsy","volume":"22","author":"Mula","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0010","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2011.03213.x","article-title":"Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review","volume":"52","author":"Taylor","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0020","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","article-title":"Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments","volume":"52","author":"Luoni","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2014.12.011","article-title":"One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E","volume":"44","author":"Micoulaud-Franchi","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0035","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","article-title":"Systematic screening allows reduction of adverse antiepileptic drug effects a randomized trial","volume":"62","author":"Gilliam","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0045","first-page":"80","article-title":"Initial development, reliability, and validity of a patient-based adverse events scale","volume":"35","author":"Baker","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yebeh.2008.11.016","article-title":"Validation of the Spanish version of the Liverpool adverse events profile in patients with epilepsy","volume":"15","author":"Carre\u00f1o","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2011.01.008","article-title":"Validation of the Chinese version of the Liverpool adverse events profile in patients with epilepsy","volume":"94","author":"Chen","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.yebeh.2011.08.005","article-title":"Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? The Portuguese\u2013Brazilian validation of the Liverpool adverse events profile","volume":"22","author":"Martins","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0065","first-page":"43","article-title":"Validity and reliability of the Korean version of the Liverpool adverse events profile (K-LAEP) in people with epilepsy","volume":"16","author":"Park","year":"2012","journal-title":"J Korean Epilepsy Soc"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yebeh.2014.08.124","article-title":"Translation, cross-cultural adaptation, and validation of the Bulgarian version of the Liverpool adverse event profile","volume":"39","author":"Kuzmanova","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0075","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.0013-9580.2004.47003.x","article-title":"The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy","volume":"45","author":"Johnson","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0080","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1528-1167.2010.02582.x","article-title":"Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?","volume":"51","author":"Kanner","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0085","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.yebeh.2004.08.019","article-title":"Determinants of quality of life in epilepsy","volume":"5","author":"Loring","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2012.10.020","article-title":"Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: a survey at two tertiary care hospitals","volume":"26","author":"Kwon","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/epi.13769","article-title":"Anxiety and depressive disorders in people with epilepsy: a meta-analysis","author":"Scott","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yebeh.2016.02.015","article-title":"Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample","volume":"57","author":"Micoulaud-Franchi","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yebeh.2003.08.019","article-title":"Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy","volume":"4","author":"Jones","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1528-1167.2012.03488.x","article-title":"Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events?","volume":"53","author":"Kanner","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yebeh.2008.09.004","article-title":"Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures","volume":"14","author":"Thapar","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.yebeh.2011.08.022","article-title":"Determinants of quality of life in people with epilepsy and their gender differences","volume":"22","author":"Yue","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yebeh.2016.02.019","article-title":"Factors affecting quality of life in adults with epilepsy in Taiwan: a cross-sectional, correlational study","volume":"58","author":"Chen","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yebeh.2012.05.005","article-title":"Depression but not seizure factors or quality of life predicts suicidality in epilepsy","volume":"24","author":"Hecimovic","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0135","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.yebeh.2011.01.010","article-title":"What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?","volume":"20","author":"Kwon","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yebeh.2006.08.022","article-title":"Validity and reliability of the Portuguese version of the quality of life in epilepsy inventory (QOLIE-31) for Brazil","volume":"10","author":"da Silva","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.yebeh.2006.01.001","article-title":"Quality of life in medication-resistant epilepsy: the effects of patient's age, age at seizure onset, and disease duration","volume":"8","author":"Szaflarski","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/01.WNL.0000138430.11829.61","article-title":"Depression and comorbidity in community-based patients with epilepsy or asthma","volume":"63","author":"Ettinger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0155","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.8_suppl_5.S9","article-title":"Optimizing health outcomes in active epilepsy","volume":"58","author":"Gilliam","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.yebeh.2013.10.001","article-title":"How do we measure psychiatric diagnoses? Implications of the choice of instruments in epilepsy","volume":"31","author":"Hesdorffer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0165","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0170","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1212\/01.wnl.0000242582.83632.73","article-title":"The association of mood with quality of life ratings in epilepsy","volume":"68","author":"Tracy","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0175","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1528-1167.2008.01938.x","article-title":"Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy","volume":"50","author":"Kwan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1600-0404.2003.00151.x","article-title":"Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea","volume":"108","author":"Choi-Kwon","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0185","first-page":"22","article-title":"Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment","volume":"62","author":"Kirmayer","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.04.005","article-title":"Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study","volume":"35","author":"Seo","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0195","series-title":"Epilepsy and the interictal state: co-morbidities and quality of life","article-title":"Quality of life in epilepsy: the key importance of the interictal state","volume":"1","author":"Ficker","year":"2015"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care","volume":"7","author":"St L","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.12962","article-title":"Indications and expectations for neuropsychological assessment in routine epilepsy care: report of the ILAE neuropsychology task force, diagnostic methods commission, 2013\u20132017","volume":"56","author":"Wilson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1006304","article-title":"The path to personalized medicine","volume":"363","author":"Hamburg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2017.07.016_bb0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yebeh.2015.12.023","article-title":"Self-control of epileptic seizures by nonpharmacological strategies","volume":"55","author":"Kotwas","year":"2016","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501730478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501730478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T15:03:17Z","timestamp":1538665397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501730478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":43,"alternative-id":["S152550501730478X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.07.016","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating quality of life in epilepsy: The role of screening for adverse drug effects, depression, and anxiety","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}